Ca2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF

Abstract

We demonstrate that BCF, as a single agent or in combination with radiation, is a novel treatment approach to the treatment of brain metastases. This paradigm shifting modality warrants further clinical trials for this unmet medical need.